Tear proteomic depletion kit development
The aim of the project
In the framework of New Hungary Development Plan Economic Development Operative Program the goal of UD-GenoMed Ltd. and its project partners is to develop a depletion kit prototype for diagnosis of diabetes complications. Diabetes mellitus is the most widespread endemic disease in the developed countries. Its most important ophthalmological complications can be prevented if they are recognized on time in the early period or the already evolved complications can be treated. Diabetic retinopathy holds the first place among blindness causing illnesses. Early recognition is based on the regular blood-sugar screening of diabetes patients, but there are no markers for forecasting ophtalmological complications. The goal of our project is to identify markers that help to recognize and monitor ophtalmological complications in the early state providing a chance to prevent and to treat them. Another advantage of diagnosis from tear is that in contrast to blood taking tear sampling is not invasive, it is not inconvenient for patients carries lower risk for infections and its cost is one tenth compared to blood taking.
Results
The official kick-off of the project will take place on Life Science Technology Day 23- 24th of May, Debrecen. We can perform the results in the future, we can only share the plan of the project now. Due to the funding of New Hungary Development Plan Economic Development Operative Program 1.1.1 we can perform the applied research of prototype development for tear proteomics applications, than we can perform prototype validation and testing it in tear biomarker discovery of diabetes. The identified biomarkers make it possible to develop a non invasive tear diagnostics for ophtalmological complications of diabetes. There are no similar diagnostics available either home or abroad.
Contact
Dr. Gábor Zahuczky |
Contacts
|